Mode
Text Size
Log in / Sign up
N/A N=70 Randomized Quadruple-blind Treatment

Perineural Local Anesthetic Administration With a Continuous Infusion Versus Automatic Intermittent Boluses

Pain, Acute · Anesthesia, Local · Trauma Injury

Enrolled (actual)
70
Serious AEs
0.0%
Results posted
May 2022
Primary outcome: Primary: Average Pain Queried on First Postoperative Day — 3; 0.0 score on a scale — p=0.033

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Continuous Infusion (Device); Automated Intermittent Boluses (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, San Diego
Primary completion
Mar 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Average Pain Queried on First Postoperative Day
3; 0.0 0.033 sig
PRIMARY
Duration of Infusion
74; 119 <0.001 sig
SECONDARY
Worst Pain
5.3; 3.3; 6.9; 4.6; 4.9; 3.6
SECONDARY
Average Pain
3.0; 1.6; 4.1; 2.0; 3.0; 1.6
SECONDARY
Least Pain
0.2; 0.1; 1.1; 0.7; 1.0; 0.4
SECONDARY
Current Pain
2.8; 1.7; 2.4; 1.6; 1.9; 1.2
SECONDARY
Opioid Consumption
1.4; 0.7; 2.0; 0.9; 1.7; 0.7
SECONDARY
Sleep Disturbances Due to Pain
1.0; 0.4; 1.5; 0.5; 0.8; 0.2
SECONDARY
Numbness in Foot and Ankle
7.5; 8.9; 5.1; 7.9; 4.5; 7.4

Summary

This will be a randomized comparison of continuous local anesthetic infusion with patient controlled boluses (PCA) to automated boluses with PCA for continuous popliteal sciatic nerve blocks. The goal will be to determine the relationship between method of local anesthetic administration (continuous with PCA initiated at discharge vs. intermittent dosing with PCA with a 5-hour delay) for continuous peripheral nerve block and the resulting pain control and duration of analgesia.

Eligibility Criteria

Inclusion Criteria

  • patients undergoing painful foot and/or ankle surgery with a planned popliteal sciatic perineural catheter for postoperative analgesia
  • age 18 years or older.

Exclusion Criteria

  • Current daily opioid use within the previous 4 weeks
  • Clinical neuro-muscular deficit of either the sciatic nerve and its branches and/or innervating muscles
  • Morbid obesity [weight > 35 kg/m2]; surgery outside of ipsilateral sciatic and saphenous nerve distributions
  • Pregnancy [as determined by a urine pregnancy test prior to any study interventions]
  • Incarceration.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04458467). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search